Patents by Inventor Jianhui Zhou

Jianhui Zhou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7933518
    Abstract: An integrated optical transceiver includes an optical receiver that produces a first electrical signal at a reception electrical interface in response to a first optical signal, an optical transmitter that emits a second optical signal in response to a second electrical signal received at a transmission electrical interface, a first optical branching device that receives the first optical signal at an reception optical interface and to direct at least a portion of the first optical signal to the optical receiver, and a second optical branching device that directs the second optical signal to an transmission optical interface. The first optical branching device directs at least a portion of the first optical signal to the second optical branching device. The second optical branching device directs the portion of the first optical signal received from the first optical branching device to the transmission optical interface.
    Type: Grant
    Filed: February 21, 2008
    Date of Patent: April 26, 2011
    Assignee: Finisar Corporation
    Inventors: Wen Li, Jianhui Zhou, Wen Huang, Fulin Pan
  • Publication number: 20100215359
    Abstract: An optical transceiver includes an electric terminal that can receive power from a host equipment and provide a power supply voltage to the optical transceiver, and a power failure monitor circuit that can detect an imminent loss of the power supply voltage. The power failure monitor circuit can produce a dying-gasp control signal when such imminent loss of power supply voltage is detected or when a disabling control signal is received from the host equipment. A driver can receive the dying-gasp control signal. An optical transmitter is powered by the power supply voltage and can emit a first optical signal under the control of the driver. The driver can modulate an envelope of the first optical signal in response to the dying-gasp control signal to produce a modulated envelope comprising a first dying gasp signal.
    Type: Application
    Filed: February 22, 2009
    Publication date: August 26, 2010
    Inventors: Wen Li, Fulin Pan, Jianhui Zhou
  • Publication number: 20090214221
    Abstract: An integrated optical transceiver includes an optical receiver that produces a first electrical signal at a reception electrical interface in response to a first optical signal, an optical transmitter that emits a second optical signal in response to a second electrical signal received at a transmission electrical interface, a first optical branching device that receives the first optical signal at an reception optical interface and to direct at least a portion of the first optical signal to the optical receiver, and a second optical branching device that directs the second optical signal to an transmission optical interface. The first optical branching device directs at least a portion of the first optical signal to the second optical branching device. The second optical branching device directs the portion of the first optical signal received from the first optical branching device to the transmission optical interface.
    Type: Application
    Filed: February 21, 2008
    Publication date: August 27, 2009
    Inventors: Wen Li, Jianhui Zhou, Wen Huang, Fulin Pan
  • Publication number: 20090203044
    Abstract: Compositions, methods and kits for diagnosing and treating cancer are provided. Therapeutic compositions may comprise agents that modulate the expression or activity of a sphingosine-1-phosphate lyase (SPL). Such compositions may be administered to a mammal afflicted with cancer. Diagnostic methods and kits may employ an agent suitable for detecting alterations in endogenous SPL. Such methods and kits may be used to detect the presence of a cancer or to evaluate the prognosis of a known disease. SPL polypeptides, polynucleotides and antibodies are also provided.
    Type: Application
    Filed: December 22, 2008
    Publication date: August 13, 2009
    Applicant: CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND
    Inventors: Julie D. Saba, Jianhui Zhou
  • Publication number: 20090116845
    Abstract: An integrated optical transceiver includes an optical receiver that receives a first optical signal that comprises input user data and a first modulation signal. The first modulation signal includes first management information. The optical receiver can output a first electrical signal comprising the first modulation signal and to output a second electrical signal comprising the input user data in response to the first optical signal. A processing unit can demodulate the first electrical signal to extract the first management information. The processing unit can produce a modulation control signal in response to second management information. An optical transmitter can output a second optical signal in response to the modulation control signal and a third electrical signal comprising output user data.
    Type: Application
    Filed: November 2, 2007
    Publication date: May 7, 2009
    Inventors: Wen Li, Jianhui Zhou, Wen Huang, Fulin Pan
  • Publication number: 20090022736
    Abstract: The invention features compositions relating to antibodies that specifically bind to the protective antigen of Bacillus anthracis, fragments thereof, and nucleic acids encoding same. The invention further features methods of using such compositions.
    Type: Application
    Filed: May 19, 2008
    Publication date: January 22, 2009
    Inventors: Donald C. Reason, Jianhui Zhou
  • Patent number: 7041291
    Abstract: Compositions, methods and kits for diagnosing and treating cancer are provided. Therapeutic compositions may comprise agents that modulate the expression or activity of a sphingosine-1-phosphate lyase (SPL). Such compositions may be administered to a mammal afflicted with cancer. Diagnostic methods and kits may employ an agent suitable for detecting alterations in endogenous SPL. Such methods and kits may be used to detect the presence of a cancer or to evaluate the prognosis of a known disease. SPL polypeptides, polynucleotides and antibodies are also provided.
    Type: Grant
    Filed: July 15, 2002
    Date of Patent: May 9, 2006
    Assignee: Children's Hospital & Research Center at Oakland
    Inventors: Julie D Saba, Jianhui Zhou
  • Publication number: 20030166897
    Abstract: Compositions, methods and kits for diagnosing and treating cancer are provided. Therapeutic compositions may comprise agents that modulate the expression or activity of a sphingosine-1-phosphate lyase (SPL). Such compositions may be administered to a marnmal afflicted with cancer. Diagnostic methods and kits may employ an agent suitable for detecting alterations in endogenous SPL. Such methods and kits may be used to detect the presence of a cancer or to evaluate the prognosis of a known disease. SPL polypeptides, polynucleotides and antibodies are also provided.
    Type: Application
    Filed: July 15, 2002
    Publication date: September 4, 2003
    Applicant: Children's Hospital & Research Center at Oakland
    Inventors: Julie D. Saba, Jianhui Zhou
  • Publication number: 20030059922
    Abstract: Compositions, methods and kits for diagnosing and treating cancer are provided Therapeutic compositions may comprise agents that modulate the expression or activity of a sphingosine-1-phosphate lyase (SPL). Such compositions may be administered to a mammal afflicted with cancer. Diagnostic methods and kits may employ an agent suitable for detecting alterations in endogenous SPL. Such methods and kits may be used to detect the presence of a cancer or to evaluate the prognosis of a known disease. SPL polypeptides, polynucleotides and antibodies are also provided.
    Type: Application
    Filed: October 30, 2002
    Publication date: March 27, 2003
    Applicant: Children's Hospital & Research Center at Oakland
    Inventors: Julie D. Saba, Jianhui Zhou
  • Patent number: 6509987
    Abstract: The number of optical channels that may be used to transmit information/data is greatly enhanced using an optical transmission facility having a transmitter that outputs optical signals having respective wavelengths within a first bandwidth, e.g., the C band, combines the latter signal with an optical signal having a wavelength between the first bandwidth and a second bandwidth, e.g., the L-band, and, using a non-linear frequency converter, processes the combined signal to form at least optical signals having wavelengths within the second bandwidth that correspond with the wavelengths of the optical signals within the first bandwidth. In this way, equipment designed for the C band may also be used to process optical signals with another, second band.
    Type: Grant
    Filed: August 10, 1999
    Date of Patent: January 21, 2003
    Assignee: Lucent Technologies
    Inventors: Guido H. Hunziker, Stan Lumish, Jianhui Zhou
  • Patent number: 6495359
    Abstract: Compositions, methods and kits for diagnosing and treating cancer are provided. Therapeutic compositions may comprise agents that modulate the expression or activity of a sphingosine-1-phosphate lyase (SPL). Such compositions may be administered to a mammal afflicted with cancer. Diagnostic methods and kits may employ an agent suitable for detecting alterations in endogenous SPL. Such methods and kits may be used to detect the presence of a cancer or to evaluate the prognosis of a known disease. SPL polypeptides, polynucleotides and antibodies are also provided.
    Type: Grant
    Filed: May 4, 2001
    Date of Patent: December 17, 2002
    Assignee: Children's Hospital Medical Center of Northern California
    Inventors: Julie D. Saba, Jianhui Zhou
  • Patent number: 6423527
    Abstract: Compositions, methods and kits for diagnosing and treating cancer are provided. Therapeutic compositions may comprise agents that modulate the expression or activity of a springiness-1-phosphate lease (SPL). Such compositions may be administered to a mammal afflicted with cancer. Diagnostic methods and kits may employ an agent suitable for detecting alterations in endogenous SPL. Such methods and kits may be used to detect the presence of a cancer or to evaluate the prognosis of a known disease. SPL polypeptides, polynucleotides and antibodies are also provided.
    Type: Grant
    Filed: September 29, 1997
    Date of Patent: July 23, 2002
    Assignee: Children's Hospital Medical Center of Northern California
    Inventors: Julie D. Saba, Jianhui Zhou
  • Patent number: 6366393
    Abstract: In an optically amplified wavelength division multiplexed (WDM) system having a WDM signal comprising a plurality of optical channels, the per-channel gain of the optical channels is kept relatively constant despite changes in input power at the optical amplifier, such as when individual optical channels of the WDM signal are added and dropped. More specifically, gain of an optical amplifier is controlled by controlling the amount of pump power supplied to the optical amplifier as a function of changes in input power which are measured in a feed-forward monitoring path. The amount of pump power for effecting gain control is adjusted according to a scaled relationship to the measured input power of the optical amplifier. By controlling the pump power directly in response to changes in input power, gain of the optical amplifier can be controlled within a sub-microsecond time scale from the time that a change in input power is detected.
    Type: Grant
    Filed: August 25, 1999
    Date of Patent: April 2, 2002
    Assignee: Lucent Technologies Inc.
    Inventors: Matthias Richard Feulner, Guido Hermann Hunziker, Bernd Teichmann, Dieter Werner, Jianhui Zhou
  • Patent number: 6212001
    Abstract: The present invention relates generally to the field of optical transmission and particularly to a method and a system for controlling optical amplification in wavelength division multiplex optical transmission. WDM systems currently under development will have eighty or more channels, i.e., modulated optical signals with different wavelengths (known as Dense Wavelength Division Multiplexing, DWDM). These DWDM systems are demanding optical amplifiers which, especially considering the cascadation of a plurality of optical amplifiers along the transmission path of the DWDM system, have only very limited tolerances in certain parameters. Among these parameters gain flatness and gain tilt are of special importance. The present invention discloses a method and a system which make use of auxiliary optical signals having a given power level which is equal for all auxiliary signals.
    Type: Grant
    Filed: January 22, 1999
    Date of Patent: April 3, 2001
    Assignee: Lucent Technologies Inc.
    Inventors: Dirk Bode, Bernd Teichmann, Jianhui Zhou
  • Patent number: 6088152
    Abstract: An optical amplifier is adapted to cancel the Raman gain of an optical transmission path that degrades those optical signals occupying the low end of the bandwidth such that the power is transferred from the latter signals to the optical signals occupying the high end of the bandwidth. More specifically, the optical amplifier adjusts the gain that it applies to the optical signals so that it favors the signal components at the low end of the bandwidth.
    Type: Grant
    Filed: March 8, 1999
    Date of Patent: July 11, 2000
    Assignee: Lucent Technologies Inc.
    Inventors: Matthias Berger, Dirk Bode, Daniel A. Fishman, Gabriela Livescu, Christian Raabe, Fatimah Shehadeh, Jianhui Zhou, Martin Zirngibl
  • Patent number: 5900969
    Abstract: An optical amplifier that receives an optical signal at an input of the optical amplifier is arranged so that it amplifies the signal and then adjusts the level of the amplified input signal to a predetermined level. The optical amplifier, which includes a filter to substantially decrease the wavelength dependence of the optical amplifier, then amplifies the adjusted signal and supplies the resulting signal to an output.
    Type: Grant
    Filed: February 14, 1997
    Date of Patent: May 4, 1999
    Assignee: Lucent Technologies Inc.
    Inventors: Atul Kumar Srivastava, James W. Sulhoff, Yan Sun, Jianhui Zhou, John Lehrer Zyskind